Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial

Grinspoon SK, DeFilippi C, Umbleja T, McCallum S, Christenson RH, Chu SM, Lu AB, Burdo TH, Aberg JA, Fichtenbaum CJ, Bloomfield GS, Malvestutto CD, Currier JS, Lu MT, Zanni MV, Douglas PS, Ribaudo HJ. Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial. JACC Adv. 2026 Jul 10;5(8):102984. doi: 10.1016/j.jacadv.2026.102984. Epub ahead of print. PMID: 42431097.


Related Posts